Development of a novel patient-reported measure for acromegaly: the Acro-TSQ

PURPOSE: Somatostatin analogs (SSAs) represent a mainstay of medical treatment for acromegaly, currently available as either intramuscular or deep subcutaneous injections. Patient-reported outcomes (PROs) are increasingly common as relevant outcomes in studies of acromegaly and its treatment, but th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pituitary
Hauptverfasser: Fleseriu, Maria, Fogelfeld, Leon, Gordon, Murray B., Sisco, Jill, Colwell, Hilary H., Ludlam, William H., Haviv, Asi, Mathias, Susan D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer US 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842345/
https://ncbi.nlm.nih.gov/pubmed/31522359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-019-00986-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge